Drug Name | Category | Label Claim | Specification (Dissolution) |
---|---|---|---|
Ibuprofen | Antiinflammatory | 80% | In-house/ USP |
Metformin HCl | Antidiabetic | 78% | USP |
Niacin | Cholesterol lowering agent | 83% | In-house |
Ciprofloxacin | Antibacterial | 74% | USP |
Drug Name | Category | Label Claim | Specification (Dissolution) |
---|---|---|---|
Atorvastatin | Lipid Lowering agent | 8.30% | In-house/ USP |
Clopidogrel | Treatmentn of acute myocardial infarction | 31.25% | In-house/ USP |
Ciprofloxacin | Antibacterial | 65% | USP |
Metformin HCl | Antidiabetic | 95% | USP |
Drug Name | Category | Label Claim | Specification (Dissolution) |
---|---|---|---|
Orlistat | Obesity management | 6% | In-house |
Iron(III) Hydroxide Polymaltose Complex & Folic ac | Vitamin & Mineral supplement | Different combination | NA |
Iron(III) Hydroxide Polymaltose Complex | Iron Supplement | Different Combination | NA |
Drug Name | Category | Label Claim | Specification (Dissolution) |
---|---|---|---|
Azithromycin | Antibacterial | 7.5% | In-house |
Clarithromycin | Antibacterial | 27% | In-house |